Fundz

Genapsys Announces $70 Million In Series D Equity Financing And Expansion Of Its Board Of Directors

PRIVATEMay 27, 2021

Amount Raised

$70 Million

Round Type

Series D

Redwood CityBiotechnology

Description

GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM Capital, and additional new investors. Proceeds from this financing will be used to continue advancing GenapSys' semiconductor based next-generation sequencing (NGS) platform.

Quick answer

Genapsys, Inc. raised $70 Million in a Series D round, dated May 27, 2021. Genapsys, Inc. is based in Redwood City, California, United States.

How much did Genapsys, Inc. raise?
Genapsys, Inc. raised $70 Million in a Series D round on May 27, 2021.
What does Genapsys, Inc. do?
GenapSys develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing.
Where is Genapsys, Inc. based and how big is it?
Genapsys, Inc. is based in Redwood City, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Genapsys, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Streamex Corp. raised $600K (Seed) on July 9, 2021.
  • Xilis raised $70M on July 9, 2021.
  • Castle Creek Biosciences, Inc raised $25M on July 9, 2021.
  • Boston Therapeutics, Inc. raised $8.4M on July 9, 2021.
  • Pulse Biosciences, Inc. raised $50M on July 9, 2021.
  • Xilis raised $70M (Series A) on July 8, 2021.

Who to call at Genapsys, Inc., and when

A new round usually means Genapsys, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Genapsys, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Genapsys, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genapsys, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Genapsys, Inc.

Location

200 Cardinal Way

Redwood City, California, United States

About

GenapSys develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Genapsys, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Genapsys, Inc.'s next move

See what Strategic adds

Genapsys, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.